发明名称 |
METABOLIC INTERVENTION WITH GLP-1 OR ITS BIOLOGICALLY ACTIVE ANALOGUES TO IMPROVE THE FUNCTION OF THE ISCHEMIC AND REPERFUSED BRAIN |
摘要 |
It has now been discovered that GLP-1 treatment after acute stroke or hemorrhage, preferably intravenous administration, can be an ideal treatment because it provides a means for optimizing insulin secretion, increasing brain anabolism, enhancing insulin effectiveness by suppressing glucagon, and maintaining euglycemia or mild hypoglycemia with no risk of severe hypoglycemia.
|
申请公布号 |
WO0066142(A3) |
申请公布日期 |
2002.01.24 |
申请号 |
WO2000US11652 |
申请日期 |
2000.05.01 |
申请人 |
BIONEBRASKA, INC. |
发明人 |
COOLIDGE, THOMAS, R.;EHLERS, MARIO, R., W. |
分类号 |
A61K45/00;A61K31/7004;A61K38/00;A61K38/26;A61P9/10;(IPC1-7):A61K38/26 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|